Evidence map›Paper›PMID 34638524›Full record

ReviewInternational journal of molecular sciences2021

Complex Organ Construction from Human Pluripotent Stem Cells for Biological Research and Disease Modeling with New Emerging Techniques.

Ryusaku Matsumoto, Takuya Yamamoto, Yutaka Takahashi

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. The Therapeutic Scope of Orofacial Mesenchymal Stem Cells.Bioengineering (Basel, Switzerland) · 2025
    Review
  3. Review
  4. Review
  5. hiPSC-Derived Cells as Models for Drug Discovery 2.0.International journal of molecular sciences · 2023
    Article
  6. The Effects of Transforming Growth Factor-BioMed research international · 2022
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ryusaku MatsumotoCenter for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan.
Takuya YamamotoCenter for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan.
Yutaka TakahashiDepartment of Diabetes and Endocrinology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.

Funding

Center for iPS Cell Research and Application not available (Fellowship Program of Development of Young Researchers)Japan Society for the Promotion of Science 18K16232Japan Society for the Promotion of Science 21J01689Ministry of Health, Labor and Welfare not available (Grants-in-Aid for Scientific Research on Hypothalamo-hypophyseal Disorders and Grants-in-Aid for Scientific Research on Endocrine Syndrome with Sexual Differentiation and Maturation)
6 · The paper itself

Abstract

Human pluripotent stem cells (hPSCs) are grouped into two cell types; embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs). hESCs have provided multiple powerful platforms to study human biology, including human development and diseases; however, there were difficulties in the establishment of hESCs from human embryo and concerns over its ethical issues. The discovery of hiPSCs has expanded to various applications in no time because hiPSCs had already overcome these problems. Many hPSC-based studies have been performed using two-dimensional monocellular culture methods at the cellular level. However, in many physiological and pathophysiological conditions, intra- and inter-organ interactions play an essential role, which has hampered the establishment of an appropriate study model. Therefore, the application of recently developed technologies, such as three-dimensional organoids, bioengineering, and organ-on-a-chip technology, has great potential for constructing multicellular tissues, generating the functional organs from hPSCs, and recapitulating complex tissue functions for better biological research and disease modeling. Moreover, emerging techniques, such as single-cell transcriptomics, spatial transcriptomics, and artificial intelligence (AI) allowed for a denser and more precise analysis of such heterogeneous and complex tissues. Here, we review the applications of hPSCs to construct complex organs and discuss further prospects of disease modeling and drug discovery based on these PSC-derived organs.

Indexed as

Biomedical ResearchCell DifferentiationCentral Nervous SystemCoculture TechniquesHumansInduced Pluripotent Stem CellsOrganoidsSynthetic BiologyTissue Engineeringartificial intelligencebioengineeringcell–cell interactioncellular heterogeneityorganoidorgan on a chippluripotent stem cellsingle-cell transcriptomicsspatial transcriptomics

Identifiers

PMID34638524
PMCPMC8508560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.